Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Tatva Chintan Pharma Chem Ltd

NSE: TATVA · BSE: 543321 · Chemicals & Petrochemicals · 28 announcements

Tatva Chintan Pharma Chem Ltd news stories on ALFA NewsRead the news →
Share price
₹1,991.20
Market cap
₹4,658 Cr
Revenue (annual)
₹505.9 Cr
Net profit (annual)
₹42.05 Cr
P/E (TTM)
90.7×Sector 36.8×
Promoter holding
72.02%+0.00% QoQ
FII holding
3.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:48 IST NSE
Capacity Expansion

Tatva Chintan Pharma Chem Capacity Expansion

Tatva Chintan Pharma Chem held a groundbreaking ceremony for a new greenfield manufacturing unit at Dahej-III, Gujarat. This expansion supports the company's long-term growth strategy.

15:46 IST NSE
Capacity Expansion

Tatva Chintan Pharma Chem Capacity Expansion: ₹200 Cr Investment

Tatva Chintan approved a Rs. 200 Crore greenfield expansion at Dahej-III, adding 344 KL reactor capacity. The board also re-appointed key directors and reported quarterly results.

Value
₹200.0 Cr
Execution
21 months